HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Hillert Selected Research

Pharmaceutical Preparations

1/2016Comparative analysis of first-year fingolimod and natalizumab drug discontinuation among Swedish patients with multiple sclerosis.
5/2013Characterization of anti-natalizumab antibodies in multiple sclerosis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Hillert Research Topics

Disease

46Multiple Sclerosis
10/2021 - 04/2000
4Relapsing-Remitting Multiple Sclerosis
01/2016 - 11/2008
4Necrosis
05/2007 - 03/2000
3Inflammation (Inflammations)
06/2010 - 11/2002
3Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
06/2010 - 04/2000
3Disease Progression
11/2008 - 08/2000
3Myasthenia Gravis
05/2007 - 03/2000
2Genetic Predisposition to Disease (Genetic Predisposition)
05/2013 - 03/2004
2Autoimmune Diseases (Autoimmune Disease)
10/2011 - 06/2008
2Stroke (Strokes)
11/2009 - 09/2008
2Alzheimer Disease (Alzheimer's Disease)
04/2002 - 10/2000
1Pediatric Obesity
03/2015
1Epstein-Barr Virus Infections
01/2012
1Infectious Mononucleosis (Glandular Fever)
01/2012
1Appendicitis
04/2011
1Arthritis (Polyarthritis)
06/2010
1Demyelinating Diseases (Demyelinating Disease)
03/2010
1Neuroinflammatory Diseases
03/2010
1Rheumatoid Arthritis
03/2010
1Atherosclerosis
11/2009
1Vascular Diseases (Vascular Disease)
11/2009
1Injection Site Reaction
10/2009
1Sarcoidosis (Schaumann Disease)
11/2008
1Headache (Headaches)
11/2008
1Glioblastoma (Glioblastoma Multiforme)
01/2007
1Carcinogenesis
01/2007
1Cluster Headache (Cluster Headaches)
11/2002
1Nervous System Diseases (Neurological Disorders)
12/2001
1Brain Death (Brain Dead)
10/2000
1Disease Susceptibility (Diathesis)
08/2000

Drug/Important Bio-Agent (IBA)

5Interferon-betaIBA
07/2010 - 03/2007
4Natalizumab (Tysabri)FDA Link
01/2016 - 06/2008
4HLA Antigens (Human Leukocyte Antigens)IBA
03/2015 - 03/2004
4AntibodiesIBA
05/2013 - 05/2007
4Neutralizing AntibodiesIBA
07/2010 - 03/2007
3HLA-A Antigens (HLA-A)IBA
01/2012 - 03/2004
3CytokinesIBA
06/2010 - 03/2000
3Messenger RNA (mRNA)IBA
05/2001 - 03/2000
2Pharmaceutical PreparationsIBA
01/2016 - 05/2013
2Myelin-Oligodendrocyte GlycoproteinIBA
06/2010 - 03/2010
2HLA-DRB1 Chains (HLA DRB1)IBA
12/2009 - 08/2000
2danaparoid (Orgaran)FDA Link
11/2009 - 09/2008
2LipidsIBA
11/2008 - 04/2002
2Cholinergic ReceptorsIBA
05/2007 - 03/2000
2Apolipoproteins E (ApoE)IBA
05/2006 - 04/2002
2HLA-DR Antigens (HLA-DR)IBA
01/2004 - 10/2001
2Nitric Oxide Synthase (NO Synthase)IBA
11/2002 - 09/2001
2CD40 Ligand (CD40L)IBA
04/2002 - 04/2000
2Proteins (Proteins, Gene)FDA Link
04/2002 - 05/2001
2HLA-DR15 antigenIBA
03/2002 - 08/2000
2Interferon-gamma (Interferon, gamma)IBA
06/2001 - 03/2000
1Vitamin DFDA LinkGeneric
10/2021
1Fingolimod Hydrochloride (FTY720)FDA Link
01/2016
1nitazoxanide (NTZ)FDA Link
01/2016
1NicotineFDA Link
07/2013
1SolventsIBA
05/2013
1Immunomodulating AgentsIBA
05/2013
1Nitrous Oxide (Laughing Gas)IBA
05/2013
1EpitopesIBA
01/2012
1interleukin-21 (interleukin 21)IBA
10/2011
1Indicators and Reagents (Reagents)IBA
04/2011
1Oligoclonal BandsIBA
07/2010
1pristane (pristan)IBA
06/2010
1Interleukin-21 ReceptorsIBA
06/2010
1Antigen-Antibody Complex (Immune Complex)IBA
03/2010
1CC ChemokinesIBA
03/2010
1CCR5 Receptors (CCR5 Receptor)IBA
11/2009
1Glatiramer Acetate (Copaxone)FDA Link
10/2009
1HLA-DRB1*03:01 antigenIBA
11/2008
1Immunoglobulin M (IgM)IBA
11/2008
1ImmunosorbentsIBA
07/2008
1EnzymesIBA
07/2008
1Interferon Regulatory FactorsIBA
06/2008
1Interferon Type IIBA
06/2008
1AntigensIBA
08/2007
1Peroxidase (Myeloperoxidase)IBA
07/2007
1B-Cell Activating FactorIBA
05/2007
1LigandsIBA
01/2007
1Tumor Necrosis Factor Ligand Superfamily Member 13IBA
01/2007
1A-factor (Streptomyces)IBA
01/2007
1ChemokinesIBA
11/2006
14-1BB Ligand (4 1BB Ligand)IBA
10/2006
1Chemokine ReceptorsIBA
09/2003
1Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2002
1ApolipoproteinsIBA
04/2002
1Q-Type Calcium Channels (Q-Type Calcium Channel)IBA
12/2001
1Leukocyte Common Antigens (CD45 Antigen)IBA
09/2001
1InterferonsIBA
06/2001
1Interleukin-18 (Interleukin 18)IBA
01/2001
124-hydroxycholesterolIBA
10/2000
1Genetic Markers (Genetic Marker)IBA
08/2000
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
06/2000
1AutoantibodiesIBA
03/2000
1Interleukin-4 (Interleukin 4)IBA
03/2000
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2000
1Interleukin-10 (Interleukin 10)IBA
03/2000

Therapy/Procedure

2Therapeutics
03/2010 - 06/2008
1Aftercare (After-Treatment)
10/2011
1Appendectomy
04/2011